Videos de Experimentos Relacionados
Función plaquetaria anormal en el síndrome de Kallmann.
Lancet (London, England)
|July 19, 1986
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.
Leukemia·2017
Same author
Genotype-phenotype dilemma in a case of sudden cardiac death with the E1053K mutation and a deletion in the SCN5A gene.
Forensic science international·2017
Same author
Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia.
Leukemia·2016
Same author
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia.
Leukemia·2016
Same author
Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial.
Bone marrow transplantation·2013
Same author
Exome sequencing identifies mutations in KIF14 as a novel cause of an autosomal recessive lethal fetal ciliopathy phenotype.
Clinical genetics·2013
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026
Same journal
Dual mobility total hip replacement in fractures: stability promotes patient confidence.
Lancet (London, England)·2026